BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6340492)

  • 21. Binding of sheep erythrocytes in chronic lymphocytic leukemias of B-cell origin.
    Semenzato G; Pizzolo G; Gerosa F; Pandolfi F; Pezzutto A; Andrighetto GC; Quinti I; Agostini C; Foa R; Tridente G
    J Clin Immunol; 1982 Oct; 2(4):296-302. PubMed ID: 6815221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new human B-lymphocyte surface antigen (BL 2) detectable by a hybridoma monoclonal antibody: distribution on benign and malignant lymphoid cells.
    Knowles DM; Tolidjian B; Marboe CC; Halper JP; Azzo W; Wang CY
    Blood; 1983 Jul; 62(1):191-9. PubMed ID: 6190520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surface markers of primate B and T lymphoid cell lines identified by antibodies to human and simian lymphocyte antigens.
    Neubauer RH; Marchalonis JJ; Strnad BC; Rabin H
    J Immunogenet; 1982 Aug; 9(4):209-21. PubMed ID: 6181170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immuno-histological diagnosis of lymphoproliferative diseases by selected combinations of antisera and monoclonal antibodies.
    Janossy G; Thomas JA; Pizzolo G; Granger SM; McLaughlin J; Habeshaw JA; Stansfeld AG; Sloane J
    Br J Cancer; 1980 Aug; 42(2):224-42. PubMed ID: 6775656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic lymphocytic leukemia and other chronic lymphoid proliferations: surface marker phenotypes and clinical correlations.
    Dillman RO; Beauregard JC; Lea JW; Green MR; Sobol RE; Royston I
    J Clin Oncol; 1983 Mar; 1(3):190-7. PubMed ID: 6607975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of a receptor for sheep erythrocytes by B lymphocytes from a chronic lymphocytic leukemia patient.
    Sitia R; Sciariada L; Zicca A; Leprini A; Ghio R; Ferrarini M
    Clin Immunol Immunopathol; 1983 May; 27(2):210-22. PubMed ID: 6223757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Separation of T lymphocytes from normal individuals and patients with B lymphocyte chronic lymphocytic leukaemia.
    Fernandez LA; MacSween JM; Langley GR
    Immunology; 1975 Feb; 28(2):231-41. PubMed ID: 1091543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The variable pattern of circulating lymphocyte subpopulations in chronic lymphocytic leukemia.
    Davis S
    N Engl J Med; 1976 May; 294(21):1150-3. PubMed ID: 1083483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunological types of lymphoproliferative disorders in a cohort: a 4-year study.
    Lowenthal RM; Sawyer PJ; Lickiss JN; Harlow RW; Kirov SM; Woods GM
    Aust N Z J Med; 1982 Aug; 12(4):258-62. PubMed ID: 6814410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic lymphocytic leukemia: a monoclonal disease.
    Solanki DL; McCurdy PR; MacDermott RP
    Am J Hematol; 1982 Sep; 13(2):159-62. PubMed ID: 6982616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SIg-E- ("null-cell") non-Hodgkin's lymphomas. Multiparametric determination of their B- or T-cell lineage.
    Knowles DM; Dodson L; Burke JS; Wang JM; Bonetti F; Pelicci PG; Flug F; Dalla-Favera R; Wang CY
    Am J Pathol; 1985 Sep; 120(3):356-70. PubMed ID: 2931028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of 1D8--a novel non-sialylated B-cell-associated carbohydrate epitope in lymphoproliferative disorders.
    Taskov H; Nikolova M; Dimitrova E
    Leuk Res; 1994 Dec; 18(12):935-41. PubMed ID: 7996874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A simultaneous assay for T-cells and B-cells using Immunobeads.
    Baran MM; Parker JW
    Am J Clin Pathol; 1985 Feb; 83(2):182-9. PubMed ID: 3881927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of helper activity for B-lymphocyte differentiation with lymphocytes having both SRBC and complement receptors in a patient with lymphoproliferative disease.
    Chiao JW; Pahwa S; Arlin ZA; Good RA
    Clin Immunol Immunopathol; 1979 Jun; 13(2):125-35. PubMed ID: 313300
    [No Abstract]   [Full Text] [Related]  

  • 35. Surface markers and prognostic factors in acute lymphoblastic leukemia.
    Tsukimoto I; Wong KY; Lampkin BC
    N Engl J Med; 1976 Jan; 294(5):245-8. PubMed ID: 53789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distribution of lymphocytes with interleukin-2 receptors (TAC antigens) in reactive lymphoproliferative processes, Hodgkin's disease, and non-Hodgkin's lymphomas. An immunohistologic study of 300 cases.
    Sheibani K; Winberg CD; van de Velde S; Blayney DW; Rappaport H
    Am J Pathol; 1987 Apr; 127(1):27-37. PubMed ID: 3105322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of T and B lymphocyte membrane markers in human non-Hodgkin malignant lymphomata.
    Brouet JC; Labaume S; Seligmann M
    Br J Cancer Suppl; 1975 Mar; 2():121-7. PubMed ID: 1081001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. B-cell malignancy and monoclonal gammopathy, and idiotype of cell surface and serum immunoglobulin.
    Sugai S; Takiguchi T; Hirose Y; Konaka Y; Shimizu S; Konda S
    Jpn J Clin Oncol; 1983 Sep; 13(3):533-42. PubMed ID: 6417376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunocytochemical staining of T and B lymphocytes in serous effusions.
    Ghosh AK; Spriggs AI; Mason DY
    J Clin Pathol; 1985 Jun; 38(6):608-12. PubMed ID: 3891789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A lymphoproliferative disorder of T-cell origin with appearances of chronic lymphatic leukemia].
    Thoden van Velzen AH; Bom-van Noorloos AA; Feltkamp-Vroom TM; von dem Borne AE; Melief CJ; Silberbusch J
    Ned Tijdschr Geneeskd; 1979 Dec; 123(51):2172-7. PubMed ID: 317509
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.